心脏术后体外生命支持中主动脉、锁骨下或股动脉插管患者的神经系统并发症:PELS观察性多中心研究结果
该回顾性多中心(34中心)观察性研究纳入2000年1月至2020年12月PELS数据库中需心脏术后ECLS的成人1897例,比较主动脉(26.5%,n=503)、锁骨下/腋动脉(20.9%,n=397)和股动脉(52.6%,n=997)插管的神经系统结局。主要复合神经终点(缺血性卒中、脑出血、脑水肿)在锁骨下/腋动脉组更常见(19.6% vs 主动脉15.8% vs 股动脉11.9%,p<0.001),混合效应模型调整后仍相关(OR 1.53 [95% CI 1.02-2.31],p=0.041)。癫痫发作在锁骨下/腋动脉组更常见(3.4% vs 主动脉1.8% vs 股动脉1.3%,p=0.036)。主动脉插管住院死亡率更高(68.4% vs 锁骨下/腋动脉56.2% vs 股动脉58.9%,p<0.001),但神经系统死因无显著差异(p=0.433)。作者认为应警惕ECLS患者的神经系统并发症并应用神经监测,尤其锁骨下/腋动脉插管时。
要点
- 心脏术后ECLS中锁骨下/腋动脉插管主要神经系统并发症发生率19.6%,高于主动脉15.8%和股动脉11.9%(p<0.001),调整后OR 1.53(95% CI 1.02-2.31,p=0.041)。
- 锁骨下/腋动脉插管癫痫发作发生率3.4%,高于主动脉1.8%和股动脉1.3%(p=0.036)。
- 主动脉插管住院死亡率68.4%,高于锁骨下/腋动脉56.2%和股动脉58.9%(p<0.001),但神经系统死因无显著差异(p=0.433)。
- 所有组神经监测使用均不频繁;作者鼓励对ECLS患者警惕神经系统并发症并使用神经监测,尤其锁骨下/腋动脉插管者。
- 锁骨下/腋动脉组高血压、吸烟、糖尿病、既往心肌梗死、透析、外周动脉疾病和既往卒中病史更常见。
适用人群与场景
- 成人需心脏术后ECLS患者,数据来自2000年1月至2020年12月PELS研究数据库,共1897例。
- 分为主动脉插管(26.5%,n=503)、锁骨下/腋动脉插管(20.9%,n=397)和股动脉插管(52.6%,n=997)三组。
研究设计与关键结果
- 研究类型:回顾性、多中心(34中心)、观察性研究,比较三种动脉插管策略的神经系统结局。
- 主要复合神经终点(缺血性卒中、脑出血、脑水肿):主动脉组n=79(15.8%),锁骨下/腋动脉组n=78(19.6%),股动脉组n=118(11.9%),p<0.001;混合效应模型调整后锁骨下/腋动脉插管与主要神经并发症相关(OR 1.53 [95% CI 1.02-2.31],p=0.041)。
- 癫痫发作:锁骨下/腋动脉组n=13(3.4%),主动脉组n=9(1.8%),股动脉组n=12(1.3%),p=0.036。
- 住院死亡率:主动脉组n=344(68.4%),锁骨下/腋动脉组n=223(56.2%),股动脉组n=587(58.9%),p<0.001(Kaplan-Meier曲线)。
- 神经系统死因:主动脉组n=12(3.9%),锁骨下/腋动脉组n=14(6.6%),股动脉组n=28(5.0%),p=0.433。
- 所有组神经监测使用均不频繁;锁骨下/腋动脉组高血压、吸烟、糖尿病、既往心肌梗死、透析、外周动脉疾病和既往卒中病史更常见。
证据类型、等级与局限
- 证据类型:回顾性、多中心(34中心)、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些结果鼓励对ECLS患者警惕神经系统并发症并使用神经监测,尤其锁骨下/腋动脉插管时。
- 原文未据此给出其他推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cerebral perfusion may change depending on arterial cannulation site and may affect the incidence of neurologic adverse events in post-cardiotomy extracorporeal life support (ECLS). The current study compares patients' neurologic outcomes with three commonly used arterial cannulation strategies (aortic vs. subclavian/axillary vs. femoral artery) to evaluate if each ECLS configuration is associated with different rates of neurologic complications.
METHODS: This retrospective, multicenter (34 centers), observational study included adults requiring post-cardiotomy ECLS between January 2000 and December 2020 present in the Post-Cardiotomy Extracorporeal Life Support (PELS) Study database. Patients with Aortic, Subclavian/Axillary and Femoral cannulation were compared on the incidence of a composite neurological end-point (ischemic stroke, cerebral hemorrhage, brain edema). Secondary outcomes were overall in-hospital mortality, neurologic complications as cause of in-hospital death, and post-operative minor neurologic complications (seizures). Association between cannulation and neurological outcomes were investigated through linear mixed-effects models.
RESULTS: This study included 1897 patients comprising 26.5% Aortic (n = 503), 20.9% Subclavian/Axillary (n = 397) and 52.6% Femoral (n = 997) cannulations. The Subclavian/Axillary group featured a more frequent history of hypertension, smoking, diabetes, previous myocardial infarction, dialysis, peripheral artery disease and previous stroke. Neuro-monitoring was used infrequently in all groups. Major neurologic complications were more frequent in Subclavian/Axillary (Aortic: n = 79, 15.8%; Subclavian/Axillary: n = 78, 19.6%; Femoral: n = 118, 11.9%; p < 0.001) also after mixed-effects model adjustment (OR 1.53 [95% CI 1.02-2.31], p = 0.041). Seizures were more common in Subclavian/Axillary (n = 13, 3.4%) than Aortic (n = 9, 1.8%) and Femoral cannulation (n = 12, 1.3%, p = 0.036). In-hospital mortality was higher after Aortic cannulation (Aortic: n = 344, 68.4%, Subclavian/Axillary: n = 223, 56.2%, Femoral: n = 587, 58.9%, p < 0.001), as shown by Kaplan-Meier curves. Anyhow, neurologic cause of death (Aortic: n = 12, 3.9%, Subclavian/Axillary: n = 14, 6.6%, Femoral: n = 28, 5.0%, p = 0.433) was similar.
CONCLUSIONS: In this analysis of the PELS Study, Subclavian/Axillary cannulation was associated with higher rates of major neurologic complications and seizures. In-hospital mortality was higher after Aortic cannulation, despite no significant differences in incidence of neurological cause of death in these patients. These results encourage vigilance for neurologic complications and neuromonitoring use in patients on ECLS, especially with Subclavian/Axillary cannulation.
参考来源
- Chiarini G, Mariani S, Schaefer AK, et al. Neurologic complications in patients receiving aortic versus subclavian versus femoral arterial cannulation for post-cardiotomy extracorporeal life support: results of the PELS observational multicenter study. Crit Care. 2024. PMID: 39113082. doi:10.1186/s13054-024-05047-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。